|
Re: apabetalone and colorectal cancer
|
1
|
Resverlogix Corp.
|
Nov 13, 2018 09:40AM
|
|
Re: AHA 2018 Resverlogix Poster #2
|
4
|
Resverlogix Corp.
|
Nov 13, 2018 09:51AM
|
|
Re: Inverted Hammer
|
4
|
Resverlogix Corp.
|
Nov 14, 2018 11:51AM
|
|
Re: Inverted Hammer
|
4
|
Resverlogix Corp.
|
Nov 15, 2018 01:04PM
|
|
NEJM Editorial on REDUCE-IT
|
3
|
Resverlogix Corp.
|
Nov 16, 2018 12:29PM
|
|
Re: Why such little intrest, so close to the finis
|
4
|
Resverlogix Corp.
|
Nov 16, 2018 04:38PM
|
|
Re: Why such little intrest, so close to the finis
|
3
|
Resverlogix Corp.
|
Nov 16, 2018 09:18PM
|
|
Re: Why such little intrest, so close to the finis
|
2
|
Resverlogix Corp.
|
Nov 19, 2018 11:49AM
|
|
Re: Primary endpoint: Time vs Absolute Numbers
|
6
|
Resverlogix Corp.
|
Nov 19, 2018 12:27PM
|
|
Re: If this trial were made up of ONLY placebo patients,..
|
3
|
Resverlogix Corp.
|
Nov 19, 2018 02:44PM
|
|
ACC 2019?
|
3
|
Resverlogix Corp.
|
Nov 19, 2018 04:45PM
|
|
Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
5
|
Zenith Epigenetics
|
Nov 20, 2018 09:58AM
|
|
Re: Zenith and Pfizer collaboration news
|
4
|
Resverlogix Corp.
|
Nov 20, 2018 10:00AM
|
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
7
|
Zenith Epigenetics
|
Nov 20, 2018 10:29AM
|
|
Apabetalone downregulates factors and pathways associated with vascular calcification
|
6
|
Resverlogix Corp.
|
Nov 20, 2018 10:37AM
|
|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
7
|
Resverlogix Corp.
|
Nov 20, 2018 02:21PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2018 10:37PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2018 11:00PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:01AM
|
|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
4
|
Resverlogix Corp.
|
Nov 21, 2018 10:05AM
|
